Phase I Clinical Trial of PCV24 in Children Aged 2 Months (Minimum 6 Weeks) to 17 Years

Clinical trial NCT06675032 · COMPLETED

Trial details

NCT number: NCT06675032
Sponsor: Reinovax Biologics Co., LTD
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pneumococcal Infectious Disease

Start date: 2024-04-27
Primary completion: 2025-05-10
Enrollment: 230

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.